<?xml version="1.0" encoding="UTF-8"?>
<p>Potent in vitro activity of CHQ has been demonstrated against SARS-CoV-2 and as a consequence, small observational studies in vivo have suggested that viral clearance is more rapid and that it inhibits progression to pneumonia when compared with controls.(
 <xref rid="R22" ref-type="bibr">22</xref>â€“
 <xref rid="R24" ref-type="bibr">24</xref>) In a study by Gautret et al., 6 of their 20 patients (there were 16 controls) on hydroxychloroquine (HCHQ) were prescribed azithromycin as well as prophylaxis for bacterial infection, and this appeared to enhance the activity of the HCHQ in terms of viral eradication, leading to a recommendation that they should be used together.(
 <xref rid="R25" ref-type="bibr">25</xref>)
</p>
